UniPharma

therapeutic areas

Rheumatology

Rheumatology is monitored by UniPharma because shifts in demand, reimbursement, regulation, competition, or supply priorities can reshape procurement and launch planning.

Related insights

Latest articles on Rheumatology

April 29, 2026

Lupus Treatment Enters Precision Immunotherapy Era

Precision immunotherapy for SLE targets specific immune pathways, shifting from broad immunosuppression to mechanism-based therapies. Implications for drug development and market access.

Read insight
April 29, 2026

Drug Shortages in JIA: Expert Commentary on Impact and Alternatives

Shortages of key corticosteroids for JIA force reliance on unlicensed alternatives, increasing service pressure and care inequalities.

Read insight
April 29, 2026

Long-Term HCQ Use Increases Risk for Retinopathy in Rheumatic Diseases: Meta-Analysis

New meta-analysis confirms dose-dependent retinopathy risk with prolonged HCQ use, underscoring the need for strict dosing and screening protocols.

Read insight
April 28, 2026

FDA Proposes Withdrawal of Avacopan Due to Manipulated Data and Liver Safety Concerns

FDA proposes to withdraw avacopan over manipulated trial data and fatal liver injury cases. Hospitals and distributors should monitor regulatory outcome.

Read insight